Patents Assigned to BioProspecting NB Inc.
  • Paralytic Peptide for Use in Neuromuscular Therapy
    Publication number: 20100305029
    Abstract: The invention relates to a method of killing or immobilizing an insect comprising administering to the insect a low molecular weight peptide isolated from the submaxiliary saliva glands of shrews of the species Blarina. The invention further relates to an insecticide composition comprising such a peptide.
    Type: Application
    Filed: June 3, 2010
    Publication date: December 2, 2010
    Applicant: BioProspecting NB Inc.
    Inventors: John M. Stewart, Bradley J. Steeves, Karl Vernes
  • Antibodies to a paralytic peptide
    Patent number: 7745588
    Abstract: The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxillary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.
    Type: Grant
    Filed: August 7, 2007
    Date of Patent: June 29, 2010
    Assignee: BioProspecting NB Inc.
    Inventors: John M. Stewart, Bradley J. Steeves, Karl Vernes
  • Paralytic peptide for use in neuromuscular therapy
    Patent number: 7485622
    Abstract: The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic.
    Type: Grant
    Filed: November 18, 2003
    Date of Patent: February 3, 2009
    Assignee: BioProspecting NB Inc.
    Inventors: John M. Stewart, Bradley J. Steeves, Karl Vernes
  • Paralytic Peptide For Use In Neuromuscular Therapy
    Publication number: 20080081784
    Abstract: The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.
    Type: Application
    Filed: August 7, 2007
    Publication date: April 3, 2008
    Applicant: BIOPROSPECTING NB INC.
    Inventors: John Stewart, Bradley Steeves, Karl Vernes
  • Paralytic Peptide For Use In Neuromuscular Therapy
    Publication number: 20080081785
    Abstract: The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxillary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.
    Type: Application
    Filed: August 7, 2007
    Publication date: April 3, 2008
    Applicant: BIOPROSPECTING NB INC.
    Inventors: John Stewart, Bradley Steeves, Karl Vernes
  • Paralytic Peptide For Use In Neuromuscular Therapy
    Publication number: 20080045458
    Abstract: The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.
    Type: Application
    Filed: August 7, 2007
    Publication date: February 21, 2008
    Applicant: BIOPROSPECTING NB INC.
    Inventors: John Stewart, Bradley Steeves, Karl Vernes
  • Paralytic peptide for use in neuromuscular therapy
    Patent number: 7273850
    Abstract: The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.
    Type: Grant
    Filed: August 21, 2006
    Date of Patent: September 25, 2007
    Assignee: Bioprospecting NB Inc.
    Inventors: John M. Stewart, Bradley J. Steeves, Karl Vernes
  • Paralytic peptide for use in neuromuscular therapy
    Patent number: 7119168
    Abstract: The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.
    Type: Grant
    Filed: June 1, 2004
    Date of Patent: October 10, 2006
    Assignee: BioProspecting NB Inc.
    Inventors: John M. Stewart, Bradley J. Steeves, Karl Vernes